Other languages Vistin Pharma ASA

Equities

VISTN

NO0010734122

Market Closed - Oslo Bors Other stock markets 10:45:00 2024-04-29 am EDT			5-day change	1st Jan Change
23.3 ^NOK	-2.51%		-3.72%	0.00%

Apr. 24	Vistin Pharma ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 24	Transcript : Vistin Pharma ASA, Q1 2024 Earnings Call, Apr 24, 2024

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vistin Pharma ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24
Vistin Pharma ASA (OB:VISTN) acquired 15% stake in CF Pharma Ltd. for ?1.6 million.	Mar. 03
Vistin Pharma ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 16
Vistin Pharma ASA Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 16
Vistin Pharma ASA Proposes an Ordinary Dividend for the Accounting Year of 2023, Payable on or About 18 June 2024 and 19 November 2024	Feb. 16
Vistin Pharma ASA Announces Cash Dividend, Payable on or About 30 January 2024	Jan. 11
Correction: Vistin Pharma Names Chief Commercial Officer as New CEO	23-10-25
Vistin Pharma Names Chief Commercial Officer as New CEO	23-10-25
Vistin Pharma ASA Appoints Magnus Tolleshaug as the New CEO From, 1 January 2024	23-10-25
Vistin Pharma ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-24
Vistin Pharma ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-22
Vistin Pharma ASA (OB:VISTN) commences an Equity Buyback Plan, under the authorization approved on May 22, 2023.	23-05-22
Vistin Pharma ASA Proposes Dividend	23-04-27
Vistin Pharma ASA Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26
Vistin Pharma ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-17
Vistin Pharma Secures Long-Term Renewable Energy Supply from Norway's Statfraft	22-12-09
Vistin Pharma ASA Enters into Long-Term Renewable Energy Supply Agreement with Statkraft	22-12-09
Vistin Pharma ASA Provides Production Guidance for the Fourth Quarter and Year 2022	22-10-26
Vistin Pharma ASA Reports Production Volume for the Third Quarter 2022	22-10-26
Vistin Pharma ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-25

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Vistin Pharma ASA

Equities

VISTN

NO0010734122

Other languages

Filters